Trial Profile
Clinical Trials Insight: 700008779
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Gemifloxacin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
- 01 Jul 2007 Results have been reported.
- 24 Nov 2005 New trial record.